Total Payments
$647.01
2024 Payments
$237.25
Companies
9
Transactions
26
Payment Breakdown by Category
Food & Beverage$647.01 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $647.01 | 26 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $280.97 | 11 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $204.77 | 7 | $0 (2024) |
| Alkermes, Inc. | $48.46 | 2 | $0 (2023) |
| Vanda Pharmaceuticals Inc. | $27.16 | 1 | $0 (2024) |
| Phadia US Inc. | $20.00 | 1 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $19.12 | 1 | $0 (2023) |
| IDORSIA PHARMACEUTICALS US INC | $17.25 | 1 | $0 (2023) |
| Xeris Pharmaceuticals, Inc. | $15.98 | 1 | $0 (2023) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $13.30 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $237.25 | 10 | Neurocrine Biosciences, Inc. ($90.62) |
| 2023 | $409.76 | 16 | ABBVIE INC. ($194.80) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $27.16 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 09/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: NEUROSCIENCE | ||||||
| 05/29/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: PSYCHIATRY | ||||||
| 05/23/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $28.57 | General |
| Category: Neuropsychiatry | ||||||
| 05/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: NEUROSCIENCE | ||||||
| 04/12/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $30.31 | General |
| Category: Neuropsychiatry | ||||||
| 03/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.09 | General |
| Category: NEUROSCIENCE | ||||||
| 02/02/2024 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $20.00 | General |
| Category: Allergy/Immunology | ||||||
| 01/24/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $31.74 | General |
| Category: Neuropsychiatry | ||||||
| 12/19/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Central Nervous System | ||||||
| 12/13/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $27.52 | General |
| Category: CNS | ||||||
| 12/07/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $118.70 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.01 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2023 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: CNS | ||||||
| 08/17/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $28.79 | General |
| Category: Neuropsychiatry | ||||||
| 08/08/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.61 | General |
| Category: NEUROSCIENCE | ||||||
| 07/27/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $8.98 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $28.60 | General |
| Category: Neuropsychiatry | ||||||
| 06/30/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $29.67 | General |
| Category: Neuropsychiatry | ||||||
| 06/08/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: NEUROSCIENCE | ||||||
| 05/16/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $27.09 | General |
| Category: Neuropsychiatry | ||||||
| 05/11/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: INSOMNIA | ||||||
About Cynthia Chiaku
Cynthia Chiaku is a Nurse Practitioner healthcare provider based in New Port Richey, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/10/2020. The National Provider Identifier (NPI) number assigned to this provider is 1255963070.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Cynthia Chiaku has received a total of $647.01 in payments from pharmaceutical and medical device companies, with $237.25 received in 2024. These payments were reported across 26 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($647.01).
Ad
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Psychiatric/Mental Health, Family
- Location New Port Richey, FL
- Active Since 02/10/2020
- Last Updated 05/09/2024
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1255963070
Products in Payments
- VRAYLAR (Drug) $263.98
- INGREZZA (Drug) $204.77
- ARISTADA (Drug) $27.52
- HETLIOZ (Drug) $27.16
- LYBALVI (Drug) $20.94
- ImmunoCAP (Device) $20.00
- Austedo XR (Drug) $19.12
- QUVIVIQ (Drug) $17.25
- QULIPTA (Drug) $16.99
- GVOKE HYPOPEN (Drug) $15.98
- CAPLYTA (Drug) $13.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in New Port Richey
Ms. Allison Lowie, Arnp, ARNP
Nurse Practitioner — Payments: $5,288
Nurse Practitioner $5,288
Jennifer Loeper, Aprn, APRN
Nurse Practitioner — Payments: $3,937
Nurse Practitioner $3,937
Pamela Sherwood, A.r.n.p, A.R.N.P
Nurse Practitioner — Payments: $3,775
Nurse Practitioner $3,775
Mrs. Patricia Evans, Anp, ANP
Nurse Practitioner — Payments: $2,174
Nurse Practitioner $2,174
Roxanne Schalles
Nurse Practitioner — Payments: $838.32
Nurse Practitioner $838.32
Maite Diaz
Nurse Practitioner — Payments: $554.91
Nurse Practitioner $554.91